TITLE

The high cost of medicines in Ireland

AUTHOR(S)
Tilson, Lesley; McGowan, Bernadette; Bennett, Kathleen; Barry, Michael
PUB. DATE
December 2004
SOURCE
European Journal of Health Economics;Dec2004, Vol. 5 Issue 4, p341
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This study compared the prices of prescription medicines in Ireland to those in other countries to determine potential cost savings on the largest community drug scheme if an alternative pricing mechanism were adopted. The analysis covered a sample of 39 drugs (44.8% of the total ingredient cost) selected from the top 70 drugs in order of total ingredient cost. Potential cost savings ranged from € 20.73 million if a Danish price were adopted, to € 16.23 million for the average European price, to € 6.82 million for the UK price. The estimated savings were statistically significant for the Danish and average European price but not for the UK price. This study demonstrates the high ex-wholesale price of prescription medications in Ireland.
ACCESSION #
16356003

 

Related Articles

  • Controlling Spending for Prescription Drugs. Altman, Stuart H.; Parks-Thomas, Cindy // New England Journal of Medicine;3/14/2002, Vol. 346 Issue 11, p855 

    Editorial. Focuses on the cost of prescription drugs in the United States. Problems with the cost of drugs for those who do not have health insurance; Cost of drugs for the elderly; Study in this issue by Lewis et al on discount drug programs for the elderly; How improving the affordability of...

  • Prescribing data shows slowdown in drug spending. Polak, Monika // GP: General Practitioner;5/3/2004, p5 

    The increase in prescribing costs has slowed down, according to data from the Prescription Pricing Authority (PPA) published last week. The PPA prescribing cost analysis for 2003 showed that almost 650 million prescription items were dispensed in 2003, costing just over pounds 7.51 billion....

  • Short-term Rx cuts could lead to long-term cost increases.  // Westchester County Business Journal;6/10/2002, Vol. 41 Issue 23, p20 

    Talks about the impact of prescription drug on health care cost increases. Factors that contributed to rising prescription drug costs; Steps that employers should consider to mitigate rising health care costs.

  • Consumer groups call for ban on internet pharmacies. Garmaise, David // Canadian HIV/AIDS Policy & Law Review;Aug2004, Vol. 9 Issue 2, p43 

    Reports that a number of consumer groups have called on the Canadian government to ban Internet pharmacies, claiming that the industry is putting the health of Canadians at risk. Statement that Internet pharmacies sell brand-name drugs to United States customers; Cost of prescription drugs in...

  • Bill will give Americans right to buy cheaper drugs. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);7/21/2001, Vol. 323 Issue 7305, p130 

    Reports that the United States House of Representatives voted to make it easier for individuals to import low cost prescription drugs from foreign countries. Concern about high drug costs among US consumers; How the bill would allow consumers to order drugs from foreign pharmacies; Opposition...

  • Free drug samples lead to greater out-of-pocket spending.  // PharmacoEconomics & Outcomes News;4/5/2008, Issue 550, p6 

    The article discusses research on the higher prescription costs by patients who receive free drug samples than those who do not. It references a study by the University of Chicago Medical Center released to the media on March 24, 2008. According to the study, medicines given as free samples are...

  • Copay assistance programs lead to higher healthcare costs.  // PharmacoEconomics & Outcomes News;10/22/2016, Vol. 764 Issue 1, p1 

    The article discusses findings of a study conducted by Peter Ubel of Duke University and Peter Bach of Memorial Sloan Kettering Cancer Center, on the impacts of copay assistance programs for expensive drugs in addressing the financial needs of patients and the risk of higher health care cost.

  • PPIs, TTOs, AND NICE GUIDELINES: DETERMINING HOW TO REDUCE PRESCRIBING COSTS. Nicholson, T.; Ingram, P.; Barman, P.; Murray, I. A. // Gut;Apr2004 Supplement 3, Vol. 53, pA22 

    This article presents information on PPIs, TTOs and NICE guidelines with the aim to reduce prescribing costs. Cornwall has the highest prescribing costs for PPIs in England and Wales. NICE has produced guidelines for cost effective PPI prescribing including treatment plans for dose and duration...

  • Canadian price controls destroying market competition.  // PharmacoEconomics & Outcomes News;3/12/2005, Issue 473, p10 

    Reports on the impact of pharmaceutical price controls imposed by Canadian authorities on market competition. Effect of the pharmaceutical policy on healthcare spending in the country; Criticism against high prices of generic drugs in Canada compared with the U.S.; Average amount spent by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics